A trial assessing feasibility and impact of levonorgestrel intrauterine system on treatment failure after endometrial ablation (EA) in women with heavy menstrual bleeding (HMB) and dysmenorrhea.
Phase of Trial: Phase IV
Latest Information Update: 27 May 2016
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Dysmenorrhoea; Menorrhagia
- Focus Therapeutic Use
- 27 May 2016 New trial record